Dr. Georges Azzi, MD

Dr. Azzi practices at Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health.

Dr. Azzi's NPI, 1265743017, was assigned on June 27, 2010. Dr. Azzi graduated from St Joseph's University Medical School in 2008. Dr. Azzi holds Florida license ME127593.

Dr. Azzi's primary practice is Holy Cross Health, at 4725 N Federal Hwy, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 771-8000.

Dr. Azzi's primary practice is Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health. The medical group on file is Holy Cross Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azzi practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Azzi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Azzi is board certified in hematology by the American Board of Internal Medicine. Dr. Azzi is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Dr. Azzi treats.

CMS data shows 1,258 Medicare services from Dr. Azzi across 8 procedure codes in 2024, for 376 Medicare patients. Medicare paid $109,958 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 376 Medicare patients who saw Dr. Azzi in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azzi's median patient age at 73, with 44% women.

In 2024, Dr. Azzi wrote 1,700 Medicare Part D claims for 213 patients. 74% of them were for generic drugs. CMS names the drug for 1,328 of them, across 48 drugs with 11 or more claims each, at $3,393,198 in total drug cost. In 2023, CMS named 1,235 claims across 45 drugs.

Dr. Azzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Azzi, published from 2010 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Biomarkers, Tumor, Antibodies, Monoclonal and Antibodies, Monoclonal, Humanized. Dr. Azzi's most frequent co-authors are Alexey A. Aleshin, MD, Toni K. Choueiri, MD and Pashtoon M. Kasi, MD, MS.

Dmand AI links Dr. Azzi to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Neoplasm, Residual, Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 1,368 general payments to Dr. Azzi from 76 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Adaptive Biotechnologies Corporation paid the most, $49,895.

Dmand AI lists 1 award for Dr. Azzi, most recently Travel Award in 2015.

Dr. Azzi graduated from St Joseph's University Medical School in 2008. Dr. Azzi is a member of ASCO.

Dr. Azzi is in network with 14 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.